These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10619595)

  • 1. Angiotensin II receptor blockade and end-organ protection.
    Chung O; Unger T
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):150S-156S. PubMed ID: 10619595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
    Unger T; Culman J; Gohlke P
    J Hypertens Suppl; 1998 Sep; 16(7):S3-9. PubMed ID: 9855025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and experimental heart failure.
    Wollert KC; Drexler H
    Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal responses to AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Cervenka L; Mitchell KD
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):45S-54S. PubMed ID: 10678288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intrarenal renin-angiotensin system in hypertension.
    Carey RM
    Adv Chronic Kidney Dis; 2015 May; 22(3):204-10. PubMed ID: 25908469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure lowering and renin-angiotensin system blockade.
    Unger T
    J Hypertens Suppl; 2003 Jul; 21(6):S3-7. PubMed ID: 14513945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Coca A; Giner V
    Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal Mas and AT
    O'Neill J; Healy V; Johns EJ
    Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
    Clark KL; Robertson MJ; Drew GM
    Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of angiotensin II antagonists in human heart failure: function of the subtype 1 receptor.
    Regitz-Zagrosek V; Neuss M; Holzmeister J; Fleck E
    J Hypertens Suppl; 1995 Jul; 13(1):S63-71. PubMed ID: 18800459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression.
    Kaiser JR; Cox BE; Roy TA; Rosenfeld CR
    Am J Physiol; 1998 Mar; 274(3):R797-807. PubMed ID: 9530248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects.
    Regitz-Zagrosek V; Neuss M; Fleck E
    Eur Heart J; 1995 Dec; 16 Suppl N():86-91. PubMed ID: 8682068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
    Balakumar P; Jagadeesh G
    Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
    Weber MA
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.